Alemtuzumab - CISMeF

Preferred Label : Alemtuzumab;

MeSH definition : An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.;

DeCS synonym : MabCambath; Lemtrada; Campath 1M; Campath 1G; Campath 1H; Campath;

MeSH hyponym : Monoclonal Antibody Campath-1H; Antibody Campath-1H, Monoclonal; Campath-1H, Monoclonal Antibody; Monoclonal Antibody Campath 1H; Campath-1H; Campath1H; Campath-1M; Campath-1-G; Campath 1 G; Campath1G; Campath-1G;

UNII : 3A189DH42V;

Details

Origin ID

D000074323;

UMLS CUI

C0383429;

ATC code(s)
- alemtuzumab [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- alemtuzumab [International Nonproprietary Name]
Currated CISMeF NLP mapping
- Alemtuzumab [NCIt concept]
- Alemtuzumab [ICD-11 Extension code]
- Alemtuzumab [Anticorps monoclonal]
- Alemtuzumab [SMS substance]
- Alemtuzumab (substance) [SNOMED CT concept]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- Lemtrada [MeSH concept]
- MabCambath [MeSH concept]
- alemtuzumab [MeSH concept]
- campath [MeSH concept]
- campath 1G [MeSH concept]
- campath 1H [MeSH concept]
- campath 1M [MeSH concept]
See also
- CD52 Antigen [MeSH Descriptor]
See also inter- (CISMeF)
- Campath-1G [NCIt concept]
- Product containing alemtuzumab (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Alemtuzumab [NCIt concept]
- Alemtuzumab (substance) [SNOMED CT concept]
- Anti-CD52 Monoclonal Antibody [NCIt concept]
- Product containing alemtuzumab (medicinal product) [SNOMED CT concept]
- alemtuzumab [ATC Code]
- alemtuzumab [International Nonproprietary Name]
Validated automatic mappings to BTNT
- alemtuzumab [ATC Code]
Validated automatic mappings to NTBT
- Anti-CD52 Monoclonal Antibody [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients